Transcriptomes of the tumor-adjacent normal tissues are more informative than tumors in predicting recurrence in colorectal cancer patients

Abstract Background Previous investigations of transcriptomic signatures of cancer patient survival and post-therapy relapse have focused on tumor tissue. In contrast, here we show that in colorectal cancer (CRC) transcriptomes derived from normal tissues adjacent to tumors (NATs) are better predict...

Full description

Bibliographic Details
Main Authors: Jinho Kim, Hyunjung Kim, Min-Seok Lee, Heetak Lee, Yeon Jeong Kim, Woo Yong Lee, Seong Hyeon Yun, Hee Cheol Kim, Hye Kyung Hong, Sridhar Hannenhalli, Yong Beom Cho, Donghyun Park, Sun Shim Choi
Format: Article
Language:English
Published: BMC 2023-03-01
Series:Journal of Translational Medicine
Subjects:
Online Access:https://doi.org/10.1186/s12967-023-04053-2
_version_ 1797831966376067072
author Jinho Kim
Hyunjung Kim
Min-Seok Lee
Heetak Lee
Yeon Jeong Kim
Woo Yong Lee
Seong Hyeon Yun
Hee Cheol Kim
Hye Kyung Hong
Sridhar Hannenhalli
Yong Beom Cho
Donghyun Park
Sun Shim Choi
author_facet Jinho Kim
Hyunjung Kim
Min-Seok Lee
Heetak Lee
Yeon Jeong Kim
Woo Yong Lee
Seong Hyeon Yun
Hee Cheol Kim
Hye Kyung Hong
Sridhar Hannenhalli
Yong Beom Cho
Donghyun Park
Sun Shim Choi
author_sort Jinho Kim
collection DOAJ
description Abstract Background Previous investigations of transcriptomic signatures of cancer patient survival and post-therapy relapse have focused on tumor tissue. In contrast, here we show that in colorectal cancer (CRC) transcriptomes derived from normal tissues adjacent to tumors (NATs) are better predictors of relapse. Results Using the transcriptomes of paired tumor and NAT specimens from 80 Korean CRC patients retrospectively determined to be in recurrence or nonrecurrence states, we found that, when comparing recurrent with nonrecurrent samples, NATs exhibit a greater number of differentially expressed genes (DEGs) than tumors. Training two prognostic elastic net-based machine learning models—NAT-based and tumor-based in our Samsung Medical Center (SMC) cohort, we found that NAT-based model performed better in predicting the survival when the model was applied to the tumor-derived transcriptomes of an independent cohort of 450 COAD patients in TCGA. Furthermore, compositions of tumor-infiltrating immune cells in NATs were found to have better prognostic capability than in tumors. We also confirmed through Cox regression analysis that in both SMC-CRC as well as in TCGA-COAD cohorts, a greater proportion of genes exhibited significant hazard ratio when NAT-derived transcriptome was used compared to when tumor-derived transcriptome was used. Conclusions Taken together, our results strongly suggest that NAT-derived transcriptomes and immune cell composition of CRC are better predictors of patient survival and tumor recurrence than the primary tumor.
first_indexed 2024-04-09T14:00:10Z
format Article
id doaj.art-8e84462bd82d4cb0b0c61ffa12e5ebda
institution Directory Open Access Journal
issn 1479-5876
language English
last_indexed 2024-04-09T14:00:10Z
publishDate 2023-03-01
publisher BMC
record_format Article
series Journal of Translational Medicine
spelling doaj.art-8e84462bd82d4cb0b0c61ffa12e5ebda2023-05-07T11:22:15ZengBMCJournal of Translational Medicine1479-58762023-03-0121111510.1186/s12967-023-04053-2Transcriptomes of the tumor-adjacent normal tissues are more informative than tumors in predicting recurrence in colorectal cancer patientsJinho Kim0Hyunjung Kim1Min-Seok Lee2Heetak Lee3Yeon Jeong Kim4Woo Yong Lee5Seong Hyeon Yun6Hee Cheol Kim7Hye Kyung Hong8Sridhar Hannenhalli9Yong Beom Cho10Donghyun Park11Sun Shim Choi12Precision Medicine Center, Future Innovation Research Division, Seoul National University Bundang HospitalDivision of Biomedical Convergence, College of Biomedical Science, Institute of Bioscience & Biotechnology, Kangwon National UniversityDivision of Biomedical Convergence, College of Biomedical Science, Institute of Bioscience & Biotechnology, Kangwon National UniversityPrecision Medicine Center, Future Innovation Research Division, Seoul National University Bundang HospitalSamsung Genome Institute, Samsung Medical CenterDepartment of Surgery, Samsung Medical Center, Sungkyunkwan University School of MedicineDepartment of Surgery, Samsung Medical Center, Sungkyunkwan University School of MedicineDepartment of Surgery, Samsung Medical Center, Sungkyunkwan University School of MedicineInstitute for Future Medicine, Samsung Medical CenterCancer Data Science Lab, Center for Cancer Research, National Cancer InstituteDepartment of Surgery, Samsung Medical Center, Sungkyunkwan University School of MedicineGeninus Inc.Division of Biomedical Convergence, College of Biomedical Science, Institute of Bioscience & Biotechnology, Kangwon National UniversityAbstract Background Previous investigations of transcriptomic signatures of cancer patient survival and post-therapy relapse have focused on tumor tissue. In contrast, here we show that in colorectal cancer (CRC) transcriptomes derived from normal tissues adjacent to tumors (NATs) are better predictors of relapse. Results Using the transcriptomes of paired tumor and NAT specimens from 80 Korean CRC patients retrospectively determined to be in recurrence or nonrecurrence states, we found that, when comparing recurrent with nonrecurrent samples, NATs exhibit a greater number of differentially expressed genes (DEGs) than tumors. Training two prognostic elastic net-based machine learning models—NAT-based and tumor-based in our Samsung Medical Center (SMC) cohort, we found that NAT-based model performed better in predicting the survival when the model was applied to the tumor-derived transcriptomes of an independent cohort of 450 COAD patients in TCGA. Furthermore, compositions of tumor-infiltrating immune cells in NATs were found to have better prognostic capability than in tumors. We also confirmed through Cox regression analysis that in both SMC-CRC as well as in TCGA-COAD cohorts, a greater proportion of genes exhibited significant hazard ratio when NAT-derived transcriptome was used compared to when tumor-derived transcriptome was used. Conclusions Taken together, our results strongly suggest that NAT-derived transcriptomes and immune cell composition of CRC are better predictors of patient survival and tumor recurrence than the primary tumor.https://doi.org/10.1186/s12967-023-04053-2Colorectal cancerNormal tissues adjacent to tumorsRecurrenceElastic net-based machine learningTumor-infiltrating immune cells
spellingShingle Jinho Kim
Hyunjung Kim
Min-Seok Lee
Heetak Lee
Yeon Jeong Kim
Woo Yong Lee
Seong Hyeon Yun
Hee Cheol Kim
Hye Kyung Hong
Sridhar Hannenhalli
Yong Beom Cho
Donghyun Park
Sun Shim Choi
Transcriptomes of the tumor-adjacent normal tissues are more informative than tumors in predicting recurrence in colorectal cancer patients
Journal of Translational Medicine
Colorectal cancer
Normal tissues adjacent to tumors
Recurrence
Elastic net-based machine learning
Tumor-infiltrating immune cells
title Transcriptomes of the tumor-adjacent normal tissues are more informative than tumors in predicting recurrence in colorectal cancer patients
title_full Transcriptomes of the tumor-adjacent normal tissues are more informative than tumors in predicting recurrence in colorectal cancer patients
title_fullStr Transcriptomes of the tumor-adjacent normal tissues are more informative than tumors in predicting recurrence in colorectal cancer patients
title_full_unstemmed Transcriptomes of the tumor-adjacent normal tissues are more informative than tumors in predicting recurrence in colorectal cancer patients
title_short Transcriptomes of the tumor-adjacent normal tissues are more informative than tumors in predicting recurrence in colorectal cancer patients
title_sort transcriptomes of the tumor adjacent normal tissues are more informative than tumors in predicting recurrence in colorectal cancer patients
topic Colorectal cancer
Normal tissues adjacent to tumors
Recurrence
Elastic net-based machine learning
Tumor-infiltrating immune cells
url https://doi.org/10.1186/s12967-023-04053-2
work_keys_str_mv AT jinhokim transcriptomesofthetumoradjacentnormaltissuesaremoreinformativethantumorsinpredictingrecurrenceincolorectalcancerpatients
AT hyunjungkim transcriptomesofthetumoradjacentnormaltissuesaremoreinformativethantumorsinpredictingrecurrenceincolorectalcancerpatients
AT minseoklee transcriptomesofthetumoradjacentnormaltissuesaremoreinformativethantumorsinpredictingrecurrenceincolorectalcancerpatients
AT heetaklee transcriptomesofthetumoradjacentnormaltissuesaremoreinformativethantumorsinpredictingrecurrenceincolorectalcancerpatients
AT yeonjeongkim transcriptomesofthetumoradjacentnormaltissuesaremoreinformativethantumorsinpredictingrecurrenceincolorectalcancerpatients
AT wooyonglee transcriptomesofthetumoradjacentnormaltissuesaremoreinformativethantumorsinpredictingrecurrenceincolorectalcancerpatients
AT seonghyeonyun transcriptomesofthetumoradjacentnormaltissuesaremoreinformativethantumorsinpredictingrecurrenceincolorectalcancerpatients
AT heecheolkim transcriptomesofthetumoradjacentnormaltissuesaremoreinformativethantumorsinpredictingrecurrenceincolorectalcancerpatients
AT hyekyunghong transcriptomesofthetumoradjacentnormaltissuesaremoreinformativethantumorsinpredictingrecurrenceincolorectalcancerpatients
AT sridharhannenhalli transcriptomesofthetumoradjacentnormaltissuesaremoreinformativethantumorsinpredictingrecurrenceincolorectalcancerpatients
AT yongbeomcho transcriptomesofthetumoradjacentnormaltissuesaremoreinformativethantumorsinpredictingrecurrenceincolorectalcancerpatients
AT donghyunpark transcriptomesofthetumoradjacentnormaltissuesaremoreinformativethantumorsinpredictingrecurrenceincolorectalcancerpatients
AT sunshimchoi transcriptomesofthetumoradjacentnormaltissuesaremoreinformativethantumorsinpredictingrecurrenceincolorectalcancerpatients